CMCR Grants Program

The Center for Medicinal Cannabis Research (CMCR) seeks to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts. Primary project awards are up to $825,000 in total costs ($275,000 per year) for up to three years. Pilot awards are up to $300,000 for two years ($150,000 per year).


2021 Request for Applications


CMCR Grants Program Studies Funded to Date.

Year Study title Principal Investigator
Full funding amount
2020 Analgesic, appetite-stimulating, and subjective effects of cannabigerol administered alone and in combination with delta-9tetrahydrocannabinol Ziva Cooper, PhD (UCLA) $825,000
2020 Effects of CBD on blood pressure and substrate metabolism during metabolic syndrome Rudy M. Ortiz, PhD (UC Merced) $300,000
2019 Effects of cannabidiol (CBD) versus placebo as an adjunct to treatment in early psychosis: Understanding the mechanism and mediators of action Kristin Cadenhead, MD (UC San Diego) $825,000
2019 Therapeutic response of cannabidiol in rheumatoid arthritis Veena Ranganath, MD (UCLA) $825,000
2019 Cannabidiol for sedative/hypnotic-sparing management of insomnia in adults Mariana Cherner, PhD (UC San Diego) $825,000
2019 Cannabidiol as a strategy to treat alcohol dependence Giordano de Guglielmo, PharmD, PhD (UC San Diego) $300,000
2019 The role of cannabidiol (CBD) in regulating meal time anxiety in anorexia nervosa: Safety, tolerability and pharmacokinetics

Guido Frank, MD (UC San Diego)